SRGN and breast carcinoma: We found that over-expression of intact serglycin slightly increased breast cancer cell growth after long term (96 h) culturing, as compared to mock-transfected (MCF-7V), or MCF-7 cells transfected with serglycin lacking GAG attachment sites (MCF-7VSG/−GAG) (Fig. 7A).